|
by Poitras, Veronica, Frey, Nina
Published 2017
“..., it is important to determine whether sufficient clinical and cost-effectiveness has been demonstrated to warrant...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Poitras, Veronica, Frey, Nina
Published 2017
“..., it is important to determine whether sufficient clinical and cost-effectiveness has been demonstrated to warrant...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
Nabilone for chronic pain management : a review of clinical effectiveness and guidelines - an update
“...The purpose of this review is to provide evidence on the clinical benefits and harms, as well...”
|
Nabilone for chronic pain management : a review of clinical effectiveness and guidelines - an update
“...The purpose of this review is to provide evidence on the clinical benefits and harms, as well...”
|
by Subramonian, Anusree, Frey, Nina
Published 2020
“...This report summarized the evidence regarding the clinical effectiveness and cost-effectiveness...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Lachance, Chantelle, Frey, Nina
Published 2020
“... cessation among youth, specific evidence is required. As such, this report aims to review the clinical...”Published 2020
Canadian Agency for Drugs and Technologies in Health
|
by Lachance, Chantelle, Frey, Nina
Published 2020
“... cessation among youth, specific evidence is required. As such, this report aims to review the clinical...”Published 2020
Canadian Agency for Drugs and Technologies in Health
- 1
- 2